Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyRalf Reilmann, Hope Heller, Beth Borowsky et al.|The Lancet Neurology|2018Cited by 108
Advocacy Recruiting for Huntington’s Disease Clinical TrialsLaVonne Goodman, Pinky Agarwal, Roger Carnes et al.|PLoS Currents|2011Cited by 8